ロード中...
The use of erythropoietin in renal failure.
The treatment of renal anaemia by recombinant human erythropoietin (EPO) is now well established. Several studies have examined the pharmacokinetics and efficacy of the drug given intravenously, intraperitoneally and subcutaneously and there is increasing evidence that the subcutaneous route has sev...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
1991
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2398938/ https://ncbi.nlm.nih.gov/pubmed/2057440 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|